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To investigate the prevalence of the recently emerging co-
listin resistance gene mcr-1 in Enterobacteriaceae among 
companion animals, we examined 566 isolates collected 
from cats and dogs in Beijing, China, during 2012–2016. Of 
these isolates, 49 (8.7%) were mcr-1–positive.
Multidrug-resistant and extensively drug-resistant gram-negative bacteria are a major threat to public health 
worldwide (1,2). The recent rapid dissemination of carbape-
nem-resistant Enterobacteriaceae has worsened this situa-
tion and further narrowed treatment options for infections 
caused by these bacteria (3). Colistin is a last-resort drug for 
treating carbapenem-resistant Enterobacteriaceae infections 
(4). In 2016, we identified the mobile colistin resistance gene 
mcr-1 (1). Soon after its description, mcr-1 was observed in 
Enterobacteriaceae from humans and food-producing ani-
mals in >30 countries on 5 continents (5). 
A 2016 article reported that a 50-year-old man who 
worked in a pet store tested positive for mcr-1–harboring 
E. coli (6). Investigation identified 6 multidrug-resistant 
mcr-1–producing E. coli isolates in samples from 4 dogs 
and 2 cats in the pet store, indicating that the pathogens can 
be transmitted between humans and companion animals. 
So far, the prevalence of mcr-1-containing Enterobacte-
riaceae in companion animals is largely unknown. In our 
study, we focused on estimating the prevalence of mcr-1 in 
Enterobacteriaceae of companion animal origin in Beijing, 
China, during 2012–2016, and investigated the presence of 
the mcr-1 gene in pet foods purchased there.
In Beijing, the total number of registered dogs and cats 
is ≈1.2 million. We collected samples from both healthy 
and sick dogs and cats in Veterinary Teaching Hospital of 
China Agricultural University. 
A total of 566 nonduplicate Enterobacteriaceae strains 
were isolated from 1,439 nasal and rectal swab samples 
collected from 1,254 dogs and 185 cats during 2012–2016. 
We also isolated 25 Enterobacteriaceae from 32 nasal 
swab samples from the pet owners. Because the food chain 
is among the main routes for humans and companion ani-
mals to acquire foodborne pathogens, we collected a small 
sample of pet foods (dog food, n = 30; cat food, n = 5) 
containing chicken as the main ingredient in Beijing during 
June–August 2016.
The species of all Enterobacteriaceae were deter-
mined by 16S rDNA sequencing and matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry of 
specimens cultured on brain–heart infusion agar plates con-
taining 2 μg/mL colistin. A total of 79/566 (14.0%) of the 
Enterobacteriaceae isolates from companion animals were 
resistant to colistin: 56 E. coli, 16 Klebsiella pneumoniae, 
5 Enterobacter cloacae, 1 Enterobacter aerogenes, and 1 
Shigella spp. PCR amplification of mcr-1 indicated that 
8.7% (49/566) of Enterobacteriaceae and 62.0% (49/79) 
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of colistin-resistant isolates harbored the mcr-1 gene, 47 E. 
coli and 2 K. pneumoniae. Only 1 E. coli isolate from a pet 
owner was colistin-resistant and mcr-1–positive. The pro-
portions of mcr-1–containing E. coli per year ranged from 
6.1% to 14.3% (Figure).
We examined the susceptibility of colistin-resistant E. 
coli to 8 other antimicrobial agents by agar dilution, ac-
cording to the recommendations of Clinical and Labora-
tory Standards Institute (7). The mcr-1–carrying E. coli 
exhibited high resistance rates to ampicillin (97.9%), cefo-
taxime (91.5%), chloramphenicol (89.4%), and gentamicin 
(85.1%) (online Technical Appendix Table 1, http://ww-
wnc.cdc.gov/EID/article/23/4/16-1732-Techapp1.pdf) but 
were susceptible to imipenem. The mcr-1–positive E. coli 
were more often resistant to amoxicillin/clavulanate, ampi-
cillin, and chloramphenicol than were the mcr-1–negative 
E. coli (p<0.05) (online Technical Appendix Table 1).
All 57 colistin-resistant E. coli were subjected to XbaI 
pulsed-field gel electrophoresis (PFGE). The 55 colistin-re-
sistant E. coli strains (2 nontypeable strains were excluded) 
were subdivided into 33 patterns and grouped into 31 clus-
ters (A–Z, AB–AF) (online Technical Appendix Figure). 
The diversity and similarity of PFGE patterns of E. coli 
from different origins suggested that the dissemination of 
mcr-1 was possibly related to both clonal expansion and 
horizontal transmission. 
Of note, the 1 E. coli colistin-resistant, mcr-1–positive 
isolate from a pet owner had the same PFGE pattern as 5 
isolates from dogs and cats. Multilocus sequence typing 
linked these 6 strains to sequence type 101. These results 
suggest that E. coli strains can be exchanged between com-
panion animals and humans.
The PCR and sequence analysis of the pet food sam-
ples showed that 7 of 35 samples were positive for mcr-1. 
Companies in China produced 5 of these foods; the other 
2 were from Italy and Belgium (online Technical Appen-
dix Table 2). These results suggest that pet foods may be 
a source from which intestinal bacteria of companion ani-
mals can acquire the mcr-1 gene.
Currently, colistin is not used to treat companion an-
imals in China. The companion animals included in this 
study were from an urban area of Beijing, so they had mini-
mal or no contact with food-producing animals in which 
colistin may have been used. Because we found mcr-1 in 
pet foods, we speculate that the pet food industry may be 
a source of mcr-1 among companion animals. Because of 
frequent and close contact between humans and compan-
ion animals, our study proposes that opportunities exist to 
transmit colistin-resistant Enterobacteriaceae to and from 
both groups. Thus, colistin-resistant Enterobacteriaceae 
from companion animals may represent a potential risk to 
human health. Further surveillance and control efforts are 
needed to reduce colistin-resistant and mcr-1–containing 
Enterobacteriaceae in companion animals and food-pro-
ducing animals.
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Figure. Proportion of colistin resistance and mcr-1 in Escherichia 
coli of companion animal origin, Beijing, China, 2012–2016.
